PMID- 29075648 OWN - NLM STAT- MEDLINE DCOM- 20180718 LR - 20181113 IS - 2314-7156 (Electronic) IS - 2314-8861 (Print) IS - 2314-7156 (Linking) VI - 2017 DP - 2017 TI - Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications. PG - 3591248 LID - 10.1155/2017/3591248 [doi] LID - 3591248 AB - Sepsis is the leading cause of death for critically ill patients in recent years. Dendritic cells (DCs) are important antigen-presenting cells and play a key role in immune response by regulating the innate and adaptive immunity. The number of DCs, the differentiation of monocytes into DCs, and the levels of surface molecules associated with the function of DCs are changed in the development of sepsis. There are many mechanisms involved in the alterations of DCs during sepsis, including the induction of apoptosis, reactive oxygen species generation, activation of the Wnt signaling pathway, epigenetic regulation, and variation in Toll-like receptor-dependent signaling. In this review, we present the classifications of DC subsets and mechanisms involved in the alterations of DCs in sepsis, as well as further discuss the therapeutic strategies targeting DCs in sepsis to improve the aberrant immune response and prolong the life during sepsis progression. FAU - Wu, Dong-Dong AU - Wu DD AUID- ORCID: 0000-0001-6739-8437 AD - School of Medical Sciences, College of Medicine, Henan University, Kaifeng, Henan 475004, China. AD - Institute of Environmental Medicine, Henan University, Kaifeng, Henan 475004, China. FAU - Li, Tao AU - Li T AD - School of Medical Sciences, College of Medicine, Henan University, Kaifeng, Henan 475004, China. FAU - Ji, Xin-Ying AU - Ji XY AUID- ORCID: 0000-0003-0690-4206 AD - School of Medical Sciences, College of Medicine, Henan University, Kaifeng, Henan 475004, China. AD - The Affiliated Nanshi Hospital of Henan University, Nanyang, Henan 473000, China. LA - eng PT - Journal Article PT - Review DEP - 20170918 PL - Egypt TA - J Immunol Res JT - Journal of immunology research JID - 101627166 RN - 0 (Toll-Like Receptors) SB - IM MH - Adaptive Immunity MH - Animals MH - Antigen Presentation MH - Apoptosis MH - Dendritic Cells/*immunology MH - Epigenesis, Genetic MH - Humans MH - Immunity, Innate MH - Immunotherapy/*methods MH - Sepsis/*immunology/therapy MH - Toll-Like Receptors/metabolism MH - Wnt Signaling Pathway PMC - PMC5624156 EDAT- 2017/10/28 06:00 MHDA- 2018/07/19 06:00 PMCR- 2017/09/18 CRDT- 2017/10/28 06:00 PHST- 2017/04/08 00:00 [received] PHST- 2017/07/24 00:00 [revised] PHST- 2017/08/08 00:00 [accepted] PHST- 2017/10/28 06:00 [entrez] PHST- 2017/10/28 06:00 [pubmed] PHST- 2018/07/19 06:00 [medline] PHST- 2017/09/18 00:00 [pmc-release] AID - 10.1155/2017/3591248 [doi] PST - ppublish SO - J Immunol Res. 2017;2017:3591248. doi: 10.1155/2017/3591248. Epub 2017 Sep 18.